Dr. Scott Louis Berger, MD, MPH

Dr. Berger practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Berger's NPI, 1487174470, was assigned on June 21, 2017. Dr. Berger graduated from University of Miami, Miller School of Medicine in 2017. Dr. Berger holds Florida license ME151255.

Dr. Berger's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Berger's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Berger to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berger practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Berger's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Berger is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Berger's licenses on file in 2 states: Florida and Washington.

Dmand AI lists acute respiratory failure, anemia, bile duct problems, cardiac arrhythmia, cirrhosis, congestive heart failure, electrolyte disorders and gastrointestinal inflammation among the conditions Dr. Berger treats.

CMS data shows 221 Medicare services from Dr. Berger across 2 procedure codes in 2024, for 73 Medicare patients. Medicare paid $21,695 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Berger in 2024. The largest group is 75 to 84, with 26 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 3.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berger's median patient age at 70, with 54% women.

In 2024, Dr. Berger wrote 514 Medicare Part D claims for 122 patients. 81% of them were for generic drugs. CMS names the drug for 196 of them, across 10 drugs with 11 or more claims each, at $16,863 in total drug cost. In 2023, CMS named 298 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Berger for performance year 2024, reported as part of a group. Dr. Berger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Berger from 3 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Davol Inc. paid the most, $157.

Dr. Berger graduated from University of Miami, Miller School of Medicine in 2017.

Dr. Berger is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.